Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRT in Hypothalamic Amenorrhea
NCT02984696Unknown
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Mar 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of estradiol and medroxyprogesterone acetate in hypothalamic amenorrhea (HA), sponsored by Università Cattolica del Sacro Cuore. Primary endpoint: Total Anti-oxidant Capacity at 6 months. Status: unknown.
02
Drugs
estradiolmedroxyprogesterone acetate
03
Conditions
hypothalamic amenorrhea (HA)
Beyond the preview
Go deeper on NCT02984696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02984696.